MedTrace Logo

Coronary Artery Disease After Heart Transplantation

NCT03583229 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2020-02-07

No results posted yet for this study

Summary

This study evaluates coronary artery disease after heart transplantation and its relation to platelet function. Furthermore, we will evaluate extracorporeal photopheresis as treatment of coronary artery disease after heart transplantation.

Conditions

  • Coronary Artery Disease in Transplanted Heart (Diagnosis)
  • Platelet Dysfunction

Interventions

DRUG

Aspirin 75mg

7 days treatment with 75 mg aspirin daily.

OTHER

Extracorporeal photopheresis

4 x ECP treatments in 60 days.

Sponsors & Collaborators

  • Aarhus University Hospital

    lead OTHER

Principal Investigators

  • Hans Eiskjær, Professor · Aarhus Universitetshospital, Afdeling for Hjertesygdomme, Palle Juul Jensens Blvd. 99, 8200 Aarhus N

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-13
Primary Completion
2021-10-01
Completion
2021-10-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03583229 on ClinicalTrials.gov